Objective: Cardiopulmonary bypass (CPB) is associated with thyroid hormone changes consistent with euthyroid sick syndrome. Similar changes have been observed after general surgical operations. Thyroid hormone changes and their association with global oxygen consumption were studied in low-risk patients undergoing coronary artery bypass grafting (CABG) with and without CPB. Methods: Fifty-two patients undergoing primary CABG by the same surgeon were randomised into either on-pump (ONCAB, n = 26) or off-pump (OPCAB, n = 26) groups. Thyroidstimulating hormone (TSH), free thyroxine (fT4) and free triiodothyronine (fT3) levels were measured at sequential time-points using chemiluminescence assays. Global oxygen consumption was measured at sequential time-points using a continuous cardiac output Swan-Ganz catheter. Results: In both groups TSH and fT4 remained within normal range throughout the study. There was a similar and progressive decline in fT3 levels with no significant difference between the groups over time ( p = 0.42). Mean fT3 levels at 24 h were below the normal range and significantly lower than baseline values (ONCAB, 3.3 AE 0.69 pmol/L vs 5.1 AE 0.41 pmol/L, p < 0.001; OPCAB, 3.3 AE 0.51 pmol/L vs 5.0 AE 0.46 pmol/L, p < 0.001). There was a significant inverse relationship between fT3 levels and global oxygen consumption. Conclusions: Off-pump surgery is associated with thyroid hormone changes similar to conventional surgical revascularisation. The data suggest that further studies into T3 administration during OPCAB may be warranted. #
Introduction
Cardiopulmonary bypass (CPB) is associated with welldescribed changes in thyroid hormone levels, consistent with what is described as the euthyroid sick syndrome [1] [2] [3] . The syndrome is characterised by depressed total (TT3) and free (fT3) triiodothyronine levels despite normal concentrations of thyroid-stimulating hormone (TSH) and total (TT4) and free (fT4) thyroxine. Decreased deiodination of T4 to its active compound T3 has been implicated as the central pathophysiologic mechanism, while there is a concomitant rise in the levels of the inactive compound reverse T3 [4] . Whether these changes represent a true hypothyroid state remains debatable. It has been noticed in trauma patients that the drop in T3 occurs at a time of increased oxygen extraction [5] , which would suggest that the change in thyroid hormone levels may merely represent an adaptive mechanism to stress, whereby the body tries to conserve energy by reducing catabolic expenditure. The possible association between thyroid hormone changes and global oxygen consumption (VO 2 ) has not been investigated in cardiac surgical patients. However, the description of perioperative thyroid hormone changes led to several animal and clinical studies that investigated the impact of T3 administration during or after CPB with conflicting results [6] [7] [8] [9] [10] .
Off-pump coronary artery bypass grafting (OPCAB) is an established modality for the surgical treatment of coronary artery disease. While it appears logical that avoidance of CPB should provide a more physiological milieu, the possible advantages or disadvantages of OPCAB need to be carefully evaluated. Some of the physiologic alterations described in surgery with CPB may be predominantly related to the fact that patients with coronary artery disease are submitted to general anaesthesia and major surgery. Immediately relevant to this is the observation that the euthyroid sick syndrome has been described in the context of general surgical operations [11, 12] . Moreover, one previous study that investigated thyroid hormone changes after coronary surgery with CPB versus OPCAB demonstrated similar changes of a euthyroid sick response in both groups [13] .
The aim of this study was to evaluate in a prospective randomised study thyroid hormone changes and their association with global oxygen consumption in low-risk patients undergoing coronary surgery with or without CPB.
Material and methods

Study design
Fifty-two patients undergoing primary elective CABG who satisfied the study criteria (Table 1) were prospectively recruited following informed consent. The study was approved by the Southampton & South West Hants joint local research ethics committee. Essentially we studied lowrisk patients in euthyroid status with normal preoperative cardiac function. Thyroid status was established by history and clinical examination and confirmed by preoperative thyroid function tests. All patients were operated by the same surgeon and there were no contraindications to OPCAB on review of the preoperative coronary angiogram. The patients were randomised into either surgery with CPB (ONCAB group, n = 26) or off-pump surgery (OPCAB, n = 26) by simple randomisation using a table of random numbers. Data from a previous study describing thyroid hormone changes using a CPB protocol similar to ours were used for sample size calculation [14] . Setting the significance level at 0.05 and the required study power at 0.9, a sample size of 44 patients would detect a difference in fT3 of 30 pg/dL between the groups at 24 h postoperatively using a two-sample t-test. The time-point of 24 h was selected because in several studies it appears to be the time that fT3 reaches a minimum postoperative value [2, 3, 14] .
Anaesthetic management
The patients' medications were continued up to the night before the operation except for anti-platelet agents, which were discontinued 7 days prior to surgery. A standardised anaesthetic protocol was followed in which fentanyl based anaesthesia was used in combination with benzodiazepine and pancuronium as a muscle relaxant. Target haemodynamic values were mean arterial pressure of above 60 mmHg and cardiac index (CI) above 2.2 L/min m 2 . Invasive monitoring included continuous cardiac output monitoring using a Swan-Ganz catheter (Edwards Lifesciences, Irvine, USA) inserted through the right internal jugular vein after anaesthetic induction. Dopamine was used as the first-line inotropic agent, while bolus intravenous injections of phenylephrine or norepinephrine infusion were used as vasoconstrictors.
CPB management
A standardised CPB protocol was used for the ONCAB patients. CPB was established using bicaval cannulae or a single two-stage venous cannula (Medtronic DLP, Medtronic UK Ltd.) inserted into the right atrium/inferior vena cava and an arterial cannula (Medtronic DLP, Medtronic UK Ltd.) placed in the ascending aorta. The circuit was primed with 1 L of Hartman's solution, 500 mL of gelofusine and 5000 IU of sodium heparin. Additional heparin, 300 IU/kg was administered intravenously prior to institution of CPB and then as required to maintain the activated clotting time (ACT) above 450 s. CPB with pulsatile flow during aortic cross-clamping was conducted under mild core hypothermia (35 8C), using a hollow-fibre membrane oxygenator (D903 Avant, Sorin Biomedica, Gloucester, UK) and arterial line filtration (D734 Micro 40, Sorin Biomedica, Gloucester, UK). Intermittent antegrade cold blood cardioplegia (4 8C) delivered through a 12G aortic root cannula was used for myocardial protection. The cardioplegic mixture consisted of 20% St Thomas' Hospital No. 2 solution (Martindale Pharmaceuticals, Essex, UK). A dose of 12 ml/kg was delivered to induce diastolic cardiac arrest and a maintenance dose of 3 ml/kg was administered after completion of each distal anastomosis. The left ventricle was vented through the aortic root during aortic cross-clamping. Flow was maintained at 2.5 L/min m 2 with judicious use of phenylephrine and phentolamine to maintain the mean perfusion pressure between 50 and 80 mmHg. Alpha-stat management of acid-base status was used. Proximal graft anastomoses on the ascending aorta were performed following aortic cross-clamp removal using a partially occluding clamp.
OPCAB technique
A median sternotomy was used for surgical access in all cases. Following harvesting of suitable conduits, the pericardium was opened and partial systemic heparinisation was employed with a target ACT of 250-300 s prior to cardiac manipulation. A single suture technique was used to facilitate exposure of the target coronary arteries. Trendelenburg posture was employed throughout the period of distal anastomoses, while a partial right lateral decubitus position was also used during exposure of the posterior descending (PDA) and the obtuse marginal (OM) coronary arteries. A mechanical suction-based myocardial tissue stabiliser (Octopus W 3; Medtronic Ltd., Watford, UK) was used to immobilise the operative field during coronary anastomosis. Following arteriotomy, an intraluminal coronary shunt (Flo-Thru; Biovascular Inc., Minnesota, USA) was inserted to maintain distal myocardial perfusion and was removed prior to completion of the anastomosis. Core temperature was maintained at or above 35 8C throughout the procedure by minimising heat loss and active warming techniques. Haemodynamic stability was achieved primarily with preload management (intravenous fluid administration and Trendelenburg posture). If preload increase did not restore target haemodynamic values, epicardial pacing or vasoactive agents were used as necessary. Following completion of coronary anastomoses, construction of the proximal anastomoses to the ascending aorta was performed in a similar fashion to on-pump techniques using an aortic side-biting clamp, with the systolic pressure maintained at or below 100 mmHg to minimise the risk of aortic dissection.
Assessment of thyroid function
Blood samples were collected from the radial artery into ethylenediaminetetraacetic acid (EDTA)-containing glass tubes shortly after anaesthetic induction, at the end of operation and 1, 6 and 24 h postoperatively. The samples were immediately centrifuged in a refrigerated centrifuge to separate the plasma, which was subsequently frozen and stored at À70 8C until assayed. Levels of fT3, fT4 and TSH were measured using the ADVIA centaur automated chemiluminescence system (Bayer Diagnostics, Newbury, UK). The reference ranges are fT4: 8.0-22.0 pmol/L, fT3: 3.5-7.0 pmol/L, TSH: 0.5-5.5 mU/L. The interassay coefficients of variation were fT4: 9.8% (n = 98), fT3: 2.9% (n = 38) and TSH: 6.8% (n = 89).
Whole-body oxygen consumption
Whole-body oxygen consumption was measured at the same time-points as thyroid hormone measurements for up to 6 h postoperatively. Blood was simultaneously drawn from the arterial line and the pulmonary artery port of the SwanGanz catheter (mixed venous blood). The following formulae were used: 
Statistical analysis
The results are expressed as the mean AE standard deviation or median with interquartile range for nonnormally distributed variables. Patient characteristics and perioperative clinical data in the two groups were compared using a two-sample Student's t-test or a Mann-Whitney Utest if normal distribution could not be assumed. Categorical variables were compared using the Pearson's chi-square or Fisher's exact test as appropriate. Repeated measures analysis of covariance, with the baseline measurement as a covariate, was used to assess the effect of time, group and group-time interaction on outcome. A paired t-test was used for intra-group comparison between individual time-points. Repeated measures analysis of covariance, with the baseline measurement as a covariate, was also used to assess the effect of inotropic support on thyroid hormone levels. Because the data contained subgroups (ONCAB vs OPCAB), Spearman's rank correlation analysis was used to investigate the association between thyroid hormone changes and whole-body oxygen consumption. The Statistical Package for Social Sciences (SPSS) version 10.1 software was used for the analysis. A p value of less than 0.05 was considered statistically significant.
Results
Patient characteristics, operative data and clinical outcome
One patient in the OPCAB group required emergency resternotomy for mediastinal bleeding 2 h postoperatively and was excluded from the study. That patient had an otherwise uneventful recovery and was discharged from hospital on the 6th postoperative day. The demographic variables for the two groups are presented in Table 2 . As outlined in the methods, these were low-risk cases and there were no significant differences between the groups. Table 3 summarises the intraoperative data and clinical outcome. The groups had a similar extent of revascularisation and only a few patients required inotropic support for a cardiac index below the target value of 2.2 L/min m 2 . Clinical outcome was similar in the two groups. No mortality or major complications, such as myocardial infarction, major neurological complications or end-organ failure were observed. No patient required the use of an intra-aortic balloon pump.
Thyroid-stimulating hormone
TSH levels remained within normal range in all patients at all sampling times. There was no baseline difference between the groups ( p = 0.83). No further analysis of the data was undertaken, however in both groups there was a similar pattern of decline in TSH concentration in the early postoperative period, with minimum values reaching 6 h postoperatively. This was followed by a partial recovery towards preoperative values at 24 h.
Free thyroxine
Free thyroxine remained within normal range in all patients throughout the study. There was no baseline difference between the groups ( p = 0.44).
Free triiodothyronine
There was no baseline difference between the groups ( p = 0.53). In both groups there was a pattern of progressive decline in fT3 levels during the study with minimum values at 24 h (Fig. 1) . Mean fT3 levels at 24 h were below the normal range and there was a highly significant difference to baseline values on paired t-test analysis in both groups ( p < 0.001 for both groups). Repeated measures ANCOVA confirmed a significant effect of time on outcome ( p = 0.01), however the effect of group ( p = 0.38) and group-time interaction ( p = 0.14) was not significant.
All thyroid hormone measurements are summarised in Table 4 .
Effect of inotropic agents
Repeated measures ANCOVA revealed no significant effect of dopamine or norepinephrine infusion on any of the measured thyroid hormones. A similar analysis was also applied separately for the ONCAB and OPCAB groups. Again, no significant effect of either dopamine or norepinephrine on thyroid hormone levels was demonstrated.
Whole-body oxygen consumption and relation to free triiodothyronine
There were no baseline differences between the groups ( p = 0.92). There was a significant and similar trend in both groups towards increasing levels of VO 2 during the study ( p < 0.001 for time and p = 0.89 for group-time interaction, Fig. 2 ). OPCAB patients maintained higher levels of VO 2 throughout the study ( p = 0.04 for the effect of group).
Spearman's rank correlation revealed a highly significant association ( p < 0.001) between VO 2 and fT3 levels (r s = À0.71).
Discussion
The study confirms previous findings of significant thyroid hormone changes after CPB [1] [2] [3] 15] . The results in the ONCAB group are similar to previous studies showing a progressive decline in fT3 levels in the early postoperative phase, despite preserved fT4 and TSH concentrations. These thyroid hormone changes are consistent with what is known as euthyroid sick syndrome, which is also characterised by raised levels of the inactive compound reverse T3 (rT3). Previous studies have confirmed the presence of elevated rT3 during and after CPB. The mechanism responsible for the development of euthyroid sick syndrome involves regulation of two deiodinases that control T4 metabolism [2, 15] . Thyroxine is three times less potent than T3 and is entirely secreted by the thyroid gland. Approximately 40% of T4 is deiodinated to the active compound, T3, in the peripheral tissues. Two deiodinases are involved in this process: 5 0 deiodinase converts T4 to T3 and rT3 to 3,3 0 T2, and 5 deiodinase converts T4 to rT3 and T3 to 3,3 0 T2. It is thought that reduced activity of 5 0 deiodinase results in decreased formation of T3, allowing increased conversion of T4 to rT3 by 5 deiodinase. Moreover, there is concomitant reduced metabolism of rT3 to 3,3 0 T2, which contributes to the raised levels of rT3 [4] . There is obvious difference between euthyroid sick state and primary hypothyroidism, in that the latter is usually characterised by decreased levels of T4 and fT4, raised concentrations of TSH and normal levels of T3 and fT3. Also primary hypothyroidism is a chronic illness, while euthyroid sick syndrome has been observed as an acute response of the thyroid axis to a variety of insults. These include general surgical operations [11, 12] , acute and chronic systemic illnesses [16] , fasting [17] and major trauma [5] .
It is interesting to note that post-surgical euthyroid sick syndrome occurs in the early postoperative phase, at a time when the patient is in a catabolic state with increased wholebody oxygen consumption and global oxygen extraction fraction [18] . Similarly, Aun et al. [5] observed that in trauma patients there was a reduction in T3 levels despite increased oxygen extraction by muscular tissue. All this would suggest that the euthyroid sick syndrome represents an adaptive mechanism of the body in an attempt to reduce catabolism [2, 4] , rather than a true hypothyroid state. In our study we observed a significant negative correlation between levels of fT3 and global oxygen consumption. In other words, fT3 levels were low at a time of high global oxygen consumption. These results would suggest that the reduced fT3 levels do not represent a hypothyroid state but an attempt of the body to reduce the metabolic rate. To the best of our knowledge, this association between fT3 and global oxygen consumption has not been previously demonstrated in cardiac surgical patients.
The documentation of low T3 levels after CPB led to a number of studies that investigated the possible beneficial effect of perioperative T3 administration. Several randomised clinical studies have been undertaken [6] [7] [8] [9] [10] , the results of which are summarised in Table 5 . Despite methodological differences between individual studies, the majority of evidence appears to demonstrate improved haemodynamic performance with T3 administration but no difference in clinical outcome. Therefore administration of T3 does not appear to have such haemodynamic impact as one would expect given the known inotropic properties of T3 and the low T3 state in the early postoperative phase. The suggestion that the euthyroid sick syndrome does not represent a true hypothyroid state may provide an explanation for these findings.
Our findings of thyroid hormone changes in the context of OPCAB are not surprising given that the euthyroid sick Fig. 2 . Perioperative VO 2 levels in the two groups. The error bars represent 95% confidence intervals around the mean (for clarity only the positive error bars are displayed for the OPCAB group and the negative for the ONCAB group). syndrome has been well-described in the context of abdominal surgery and major trauma, which makes it plainly obvious that stress other than the use of CPB can also elicit this hormonal response. What is more interesting is the fact that the magnitude of thyroid hormone changes was similar in the two groups, which is in keeping with the observations by Cerillo et al. [13] of similar thyroid hormone changes after coronary surgery with CPB versus OPCAB. One would intuitively expect some benefit conferred by the avoidance of CPB. There are certainly factors associated with the use of CPB per se that have been debated for some time as possible explanations for the development of euthyroid sick syndrome after open-heart surgery. Hypothermia during CPB, haemodilution, the use of non-pulsatile flow and hypothalamopituitary-thyroid axis dysfunction have all been proposed as contributory factors. Thrush et al. [14] undertook a thorough assessment of thyroid function in a randomised study comparing normothermic (35 AE 1 8C) versus hypothermic (26 AE 5 8C) nonpulsatile CPB in 13 low-risk patients undergoing primary CABG or valve replacement surgery. Both groups developed changes consistent with euthyroid sick syndrome, however there was no difference between the groups. These findings are supported by the study of Lehot et al. [19] , where no difference in thyroid function was found between hypothermic and normothermic non-pulsatile CPB in 20 patients.
Haemodilution by the CPB circuit priming volume is unlikely to be a major factor affecting thyroid hormone changes postoperatively, since albumin concentrations return to normal by 2 h after CPB, while changes in thyroid hormone levels persist for several days [1, 2, 14] . Moreover, thyroid hormone changes move in opposite directions during and after CPB, suggesting that despite their structural similarity they are affected by haemodilution in a different way. Even after correcting for haemodilution, Bremner et al. reported thyroid hormone changes of a euthyroid sick response [15] . All this indicates that haemodilution is not a major factor affecting thyroid hormone levels [2] .
The lack of pulsatile flow is perhaps the only factor that has been shown to significantly affect the magnitude of thyroid hormone changes during CPB. Buket et al. [3] examined thyroid hormone changes in 30 low-risk patients undergoing CABG with hypothermic (26-30 8C) CPB using pulsatile versus non-pulsatile flow. The authors observed the development of euthyroid sick syndrome in both groups. However, total T3 and fT3 concentrations declined significantly less with pulsatile CPB. Immediately relevant to these findings is the pioneering work by Taylor and Bremner in the late 1970s. Their group investigated the hypothalamopituitary-thyroid axis function during CPB [15, 20, 21] . They found a blunted TSH response to thyrotropin-releasing hormone (TRH) during both the early and late phase of CPB, in contrast to heparinised and non-heparinised patients undergoing major surgery [15, 20] . This led them to repeat the study of TRH administration in 20 patients undergoing normothermic pulsatile versus non-pulsatile CPB [21] . There was a marked difference between the groups, with nonpulsatile patients demonstrating the previously reported subnormal response to TRH, while pulsatile CPB resulted in a normal pituitary response to TRH in nine out of ten patients. These studies provide strong evidence that pulsatile flow during CPB is a major factor contributing towards preservation of a euthyroid hormonal environment.
Careful review of the literature therefore reveals that various factors pertinent to the use of CPB, such as hypothermia and haemodilution, have not been proven to play a major role in perioperative thyroid hormone changes. The only significant factor appears to be the use of pulsatile or non-pulsatile flow during CPB [3, 15, 21] . The importance of pulsatile flow and the observation that relatively minor general surgical procedures lead to a euthyroid sick syndrome [11, 12] would suggest that haemodynamic factors and the stress of a surgical procedure may be the paramount factors that determine thyroid axis response. This may explain why OPCAB led to a thyroid response comparable to CPB.
The presence of significant transient haemodynamic impairment during distal anastomoses in OPCAB has been well documented [22] [23] [24] . Significant drops in cardiac output may occur despite relatively well-preserved systemic arterial pressures. Cardiac manipulation for distal anastomoses results in compression of the right heart chambers against the surrounding fibrous pericardium and pleura and mechanical dysfunction of the right ventricle [25] . It is conceivable that the cumulative effect of these transient episodes of reduced cardiac output and reduced perfusion pressure in the course of distal anastomoses in OPCAB generate a thyroid axis response comparable to surgery with CPB.
One limitation of this study is that it included a wellselected, low-risk patient population with normal cardiac and endocrine function. This study design ensured homogeneity of the groups, which is essential in prospective randomised studies with small numbers of patients. The results cannot be extrapolated on patients with a higher risk profile. Patients with poor left ventricular function, thyroid disease or other major comorbidities, such as diabetes mellitus or extracardiac arteriopathy may behave differently and this should be the subject of a separate study.
In conclusion this study has demonstrated the presence of thyroid hormone changes during OPCAB comparable to those observed after CPB and consistent with the post-surgical euthyroid sick syndrome. These results indicate that the use of mildly hypothermic pulsatile CPB for relatively brief periods of time in low-risk patients is not the prime pathophysiologic mechanism responsible for the development of euthyroid sick response. Furthermore, a significant negative correlation was found between VO 2 and fT3 levels, indicating that the thyroid hormone changes do not represent a true hypothyroid state. Whether these findings would be applicable in a high-risk patient population and whether there may be a place for T3 administration in OPCAB remains to be seen.
